Surgical removal of bleeding in the brain
Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
This study tests if surgically removing bleeding in the brain can help people aged 20 to 70 recover better from a severe type of stroke.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06816641 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and effectiveness of surgically removing spontaneous intracerebral hemorrhage (ICH), a severe type of stroke characterized by bleeding within the brain. It focuses on understanding how this intervention impacts clinical outcomes and identifies prognostic factors that may influence recovery. The study includes patients aged 20 to 70 with radiological evidence of ICH, while excluding those with traumatic causes or significant comorbidities. The goal is to improve treatment strategies for ICH and reduce associated mortality rates.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20-70 with radiological findings of spontaneous intracerebral hemorrhage.
Not a fit: Patients with traumatic ICH, significant comorbidities, or those on anticoagulant therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve recovery outcomes for patients suffering from spontaneous intracerebral hemorrhage.
How similar studies have performed: Other studies have explored surgical interventions for ICH, showing varying degrees of success, but this specific approach is being assessed for its unique efficacy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients with radiological findings of ICH. * Age group 20-70 years. Exclusion Criteria: * • Traumatic ICH or ruptured aneurysm or AVM or brain tumor. * Postoperative cranial surgery ICH. * Secondary hydrocephalus. * Patients with other comorbidities e.g., Liver cell failure and renal cell failure. * Patients with bleeding disorders. * Patients who are regular on anticoagulant or antiplatelet therapy. * Small sized ICH\< 30 ml. * GCS less than 6 preoperatively.
Where this trial is running
Sohag
- Sohag University hospitals — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Mohamed A Ragheb, Demonstrator
- Email: raghibov@gmail.com
- Phone: 01025921006
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.